Affini-T Therapeutics, a biotech with roots at Fred Hutch, raises $175M for cancer treatments By: Puget Sound Business Journal (Seattle) via Business Journals March 22, 2022 at 17:50 PM EDT The company, which has research labs in Seattle, is focusing on cell therapies for solid tumor cancers. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
